New York Times columnist and former Nixon speechwriter William Safire is the latest prominent conservative to endorse embryonic stem cell research. Yesterday, Safire devoted his column to his hope that former president Ronald Reagan’s long battle with Alzheimer’s may help to break the impasse blocking greater federal support of research into the cells and their potential to help millions of American’s including those with Alzheimer’s.
Safire cogently argues that
this research, whether the government likes it or not, is growing apace. Unless we act now to direct it toward morally acceptable ends–cure and treatment of disease and the extension of active life, not monstrous manipulation and production of clones for spare parts–we risk losing the imperfectability that makes us human.
This is the point that many opponents of stem cell research miss: that by not funding embryonic stem cell research, which will continue regardless, the federal government misses its chance to effectively shape and regulate the direction that research takes.
10 Breakthrough Technologies 2024
Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.
Scientists are finding signals of long covid in blood. They could lead to new treatments.
Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.
AI for everything: 10 Breakthrough Technologies 2024
Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.
What’s next for AI in 2024
Our writers look at the four hot trends to watch out for this year
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.